Jefferies Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Jefferies Group’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-55,300	Closed	-$6.06M	–	2186
2021 Q3	$6.06M	Buy	+55,300	New	+$5.74M	0.04%	388
2021 Q1	–	Sell	-4,400	Closed	-$322K	–	2178
2020 Q4	$322K	Sell	4,400 -18,900	-81%	-$1.4M	﹤0.01%	1263
2020 Q3	$1.81M	Buy	+23,300	New	+$1.6M	0.02%	608
2019 Q2	–	Sell	-118,000	Closed	-$3.12M	–	3066
2019 Q1	$3.12M	Buy	118,000 +500	+0.4%	+$11.8K	0.03%	663
2018 Q4	$2.3M	Buy	+117,500	New	+$2.3M	0.02%	754
2017 Q1	–	Sell	-16,900	Closed	-$273K	–	2800
2016 Q4	$273K	Buy	+16,900	New	+$306K	﹤0.01%	1803
2015 Q3	–	Sell	-7,200	Closed	-$250K	–	3415
2015 Q2	$250K	Buy	+7,200	New	+$220K	﹤0.01%	1865
2014 Q3	–	Sell	-49,000	Closed	-$775K	–	2584
2014 Q2	$775K	Buy	+49,000	New	+$699K	0.01%	1018

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Jefferies Group's HZNP Position: Q3 2022 in Review

Jefferies Group increased its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 3,463% in Q3 2022, buying an estimated $16.1M and bringing the position to 237,185 shares worth $14.7M. The position accounts for 0.12% of the portfolio, ranked #125.

Jefferies Group first reported a position in HZNP in Q1 2014 and has held it in 24 quarters since. 530 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

Jefferies Group held 237,185 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $14.7M as of Q3 2022.
Jefferies Group bought 230,528 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $16.1M.
Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.12% of Jefferies Group's portfolio in Q3 2022, its #125 holding.
Jefferies Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2014 and has held it in 24 quarters since.
530 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.